Intracranial Stents Market 2024-2033: Technological Advancements, Competitive Landscape and Strategies

The intracranial stents global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Intracranial Stents Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size -
The intracranial stents market size has grown rapidly in recent years. It will grow from $0.42 billion in 2023 to $0.49 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increased awareness of stroke risks, improved patient education, rise in radiation safety measures, increased aging population, emergence of minimally invasive techniques.

The intracranial stents market size is expected to see rapid growth in the next few years. It will grow to $0.87 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to expansion of telehealth services, adoption of genomic medicine, rising healthcare infrastructure, expansion of stroke rehabilitation services, rising health initiatives. Major trends in the forecast period include adoption of bioresorbable intracranial stents, adoption of neurointerventional robotics, integration of advanced imaging technologies, adoption of pediatric intracranial stents, developing dual antiplatelet therapy strategies.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report


Scope Of Intracranial Stents Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Intracranial Stents Market Overview

Market Drivers -
The increase in incidence of a brain aneurysm is expected to propel the growth of the intracranial stents market in the coming years. A brain aneurysm is the development of a bulge in the blood vessels of the brain. This bulge may rupture or burst and can cause brain haemorrhage, which may lead to the death of the patient. Intracranial vessel stenting (IVS) is a minimally invasive treatment for treating serious cerebral artery stenosis. The weakening of the arteries that deliver blood to the brain is known as cerebral artery stenosis. For instance, in February 2023, according to the Medical News Today, a UK-based medical news website, about 3.2% of persons worldwide have unruptured aneurysms. Thus, the increasing incidence of a brain aneurysm will drive the intracranial stents market growth.

Market Trends -
Major companies operating in the intracranial stents market are innovating new products such as Onyx Frontier drug-eluting stent (DES) to increase their profitability in the market. Onyx Frontier is a drug-eluting stent (DES) used to treat coronary artery disease (CAD), which is brought on by plaque accumulation inside the coronary arteries. For instance, in August 2022, Medtronic plc, an Ireland-based medical devices company launched Onyx Frontier drug-eluting stent (DES). The stent's architecture makes it ideal for sophisticated percutaneous cardiac intervention (PCI) and is highly deliverable. The Resolute Onyx DES's acute performance and clinical data provide the foundation for the Onyx Frontier DES, which provides a better delivery mechanism and greater acute performance.

The intracranial stents market covered in this report is segmented –
1) By Type: Self Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization
2) By Disease Indication: Brain Aneurysm, Intracranial Stenosis
3) By End-User: Hospitals, Ambulatory Surgery Centers, Other End-Users

Get an inside scoop of the intracranial stents market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=5169&type=smp


Regional Insights -
North America was the largest region in the intracranial stents market in 2023. Asia-Pacific is expected to be the fastest region in the intracranial stents market share during the forecast period. The regions covered in the intracranial stents market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies -
Major companies operating in the intracranial stents market include Medtronic plc, Balt Extrusion LLC., Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Acandis GmbH, Admedes Schuessler GmbH, MicroVention Inc., Phenox GmbH, Terumo Corporation, Johnson & Johnson Services Inc., Abbott Laboratories, Brainlab AG, Cardiatis SA, Cook Medical LLC, DePuy Synthes, Endologix Inc., InspireMD Inc., Integra LifeSciences Corporation, Kaneka Corporation, Kerecis Limited, Penumbra Inc., Rapid Medical Ltd., Vascular Solutions Inc., W. L. Gore & Associates Inc., Biotronik SE & Co. KG, Cardionovum GmbH, Codman Neuro, C.R. Bard Inc., Cerebral Stents.

Table of Contents
1. Executive Summary
2. Intracranial Stents Market Report Structure
3. Intracranial Stents Market Trends And Strategies
4. Intracranial Stents Market – Macro Economic Scenario
5. Intracranial Stents Market Size And Growth
…..
27. Intracranial Stents Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model



 

Comments

Post a Comment

Popular posts from this blog

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Bradykinesia Market 2026–2030: Factors Driving Growth, Demand, And Revenue Expansion

Image
  The bradykinesia market size has grown rapidly in recent years. It will grow from $3.41 billion in 2025 to $3.88 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to parkinson’s disease prevalence, aging population, levodopa therapy adoption, neurology clinic expansion, symptom-based treatment. The bradykinesia market size is expected to see rapid growth in the next few years. It will grow to $6.38 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to neurological drug innovation, early diagnosis adoption, digital disease monitoring, geriatric care growth, personalized neurology. Major trends in the forecast period include increased use of combination parkinson’s therapies, focus on early-stage disease management, expansion of dopaminergic drug use, growth of personalized neurological care, adoption of long-term symptom control strategies. Cla...
Read more

Global Haptic Virtual Reality (VR) Fitness Suit Market Analysis Highlights Emerging Opportunities And Revenue Forecasts Through 2030

Image
  The haptic virtual reality (vr) fitness suit market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to rising popularity of virtual fitness applications, increasing consumer interest in immersive workouts, growth of wearable fitness technologies, expansion of home-based fitness solutions, improvements in haptic hardware capabilities. The haptic virtual reality (vr) fitness suit market size is expected to see exponential growth in the next few years. It will grow to $5.4 billion in 2030 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to increasing adoption of ai-driven fitness personalization, rising demand for remote and virtual training solutions, expansion of rehabilitation and therapeutic vr applications, growing integration of biometric feedback systems, advan...
Read more